Showing results (11-20 of 267) with videos related to
Sort By:
Pageof 27
Current Medicinal Chemistry|April 9, 2008
New tubulin polymerization inhibitor derived from thalidomide: implications for anti-myeloma therapyMasahiro Kizaki, Yuichi HashimotoMolecular Neurobiology|December 10, 2009
Humanin and the receptors for humaninMasaaki Matsuoka, Yuichi HashimotoJournal of Neurochemistry|March 21, 2014
A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicityYuichi Hashimoto, Masaaki MatsuokaBioorganic & Medicinal Chemistry Letters|August 10, 2007
3,3-diphenylpentane skeleton as a steroid skeleton substitute: novel inhibitors of human 5alpha-reductase 1Shinnosuke Hosoda, Yuichi HashimotoFuture Medicinal Chemistry|April 1, 2017
Progress in the medicinal chemistry of silicon: C/Si exchange and beyondShinya Fujii, Yuichi HashimotoBioorganic & Medicinal Chemistry|July 30, 2005
Nuclear receptor antagonists designed based on the helix-folding inhibition hypothesisYuichi Hashimoto, Hiroyuki MiyachiChemical Record (New York, N.Y.)|November 5, 2003
Synthesis of marine guanidine alkaloids and their application as chemical/biological toolsKazuo Nagasawa, Yuichi HashimotoPPAR Research|June 21, 2008
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile TemplateHiroyuki Miyachi, Yuichi HashimotoThe Biochemical Journal|November 26, 2011
MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilinsNobuyuki Tachi, Yuichi Hashimoto, Masaaki MatsuokaYakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2011
[Structural development study of a novel pharmacological chaperone for folding-defective rhodopsin mutants responsible for retinitis pigmentosa]Kenji Ohgane, Kosuke Dodo, Yuichi HashimotoPageof 27